US Patent 9890208 Compositions and methods for treating inflammation and fibrosis
Patent 9890208 was granted and assigned to Maine Medical Center on February, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+199 characters)
Article
Patent abstract
The present invention features compositions featuring agents that bind to denatured collagen and methods of using such agents to treat or prevent fibrosis or inflammation in a subject.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Jennifer M. Caron0
Leif Oxburgh0
Peter C. Brooks0
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09890208 Compositions and methods for treating inflammation and fibrosis US Patent 9890208 Compositions and methods for treating inflammation and fibrosis
Infobox
Patent Number
098902080
Patent Number
98902080
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
098902080
Date of Patent
February 13, 2018
0Patent Application Number
144887530
Date Filed
September 17, 2014
0Patent Primary Examiner
Edits on 18 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09890208 Compositions and methods for treating inflammation and fibrosis
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09890208
Date of patent
February 13, 2018
Patent application number
14488753
Date Filed
September 17, 2014
Patent primary examiner
Find more entities like US Patent 9890208 Compositions and methods for treating inflammation and fibrosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
